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Abstract
We present a mechanistic model of drug release from a multiple emulsion into an external
surrounding fluid. We consider a single multi-layer droplet where the drug kinetics are described
by a pure diffusive process through different liquid shells. The multi-layer problem is described
by a system of diffusion equations coupled via interlayer conditions imposing continuity of drug
concentration and flux. Mass resistance is imposed at the outer boundary through the application
of a surfactant at the external surface of the droplet. The two-dimensional problem is solved
numerically by finite volume discretization. Concentration profiles and drug release curves are
presented for three typical round-shaped (circle, ellipse and bullet) droplets and the dependency
of the solution on the mass transfer coefficient at the surface analyzed. The main result shows
a reduced release time for an increased elongation of the droplets.
Keywords: droplets, nanoemulsions, drug release, multi-layer diffusion, numerical solutions.
1 Introduction
Multiple emulsions consist of a dispersion of immiscible spherical fluid droplets, of diameter ranging
from 1 to 50 µm, in a larger fluid drop, of size up to 100µm [1–4]. The simplest low-ordered real-
ization is the double emulsion, where, for instance, a water core is surrounded by a thin concentric
oil layer. If the double emulsion is immersed in water, it is often termed as a water/oil/water
(W/O/W) emulsion. More complex examples include collections of polydisperse droplets placed
in a larger drop or multi-layer distinct cores of fluid [4, 5]. Their stability is generally guaranteed
by a surfactant (adsorbed onto the external interface) which prevents coalescence of the droplets
[2, 3, 6, 7]. Such emulsions are conventionally manufactured by means of microfluidic devices,
which, alongside a large production rate, ensure a high degree of reproducibility [4]. Due to their
compartmental structure, these systems are extensively used to encapsulate and transport active
components in a number of technological applications, including food processing [8, 9], cosmetics
[10, 11], syntheses of microspheres and microcapsules [2, 12–14], to name a few.
Multi-layered emulsions are particularly suited as drug carriers of pharmaceutical and biological
compounds, due to their capability to combine an efficient mechanical stability to a controlled
release of the cargo within the range of the therapeutic window [15, 16]. Indeed, unlike a layer-free
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emulsion, the multi-layer assembly ensures protection of the active agent against external chemical
aggression as well as an enhanced control of the transfer rate by the thin oil barrier [17, 18].
These features drastically diminish the premature degradation of the compound and broaden the
sustainability of the emulsion. A further benefit stems from its inherent soft structure, which can be
selectively hardened or gelled by tuning the viscosity of the middle fluid layer [19, 20]. In contrast to
rigid capsules, this allows for, for instance, migration through narrow interstices where large shape
deformations are expected to occur.
Although many efforts have been dedicated to the experimental realization of optimized drug-
delivery via multiple emulsions, much less is known about the underlying mechanism governing the
drug release in these systems. In pharmaceutical applications, the drug is usually stored within the
internal water droplet and then, after diffusing through the surrounding oil shell, is subsequently
released in the external medium. Amongst several physico-chemical processes, such as osmosis and
drug dissolution, diffusion is by far the dominant mechanism controlling drug kinetics and release
[21]. This process is crucially influenced by the medium properties as well as by the ultra-thin
surfactant layer confined at the droplet interface. Indeed, the latter may partially hinder the mass
flux of the drug towards the external medium and, hence, potentially compromise its efficacy [16].
In many practical situations, such as a capsule migrating in a blood vessel, emulsions are dragged
by the surrounding fluid. Even under weak shears (those typical of a laminar regime in a microfluidic
channel), the flow is known to produce relevant shape deformations that may potentially alter the
functioning of the multi-core emulsion as a drug carrier [22–26]. Under a mild steady extensional
flow, for instance, a spherical-shaped double emulsion may turn into an ellipsoid [22–24], whereas
bean or bullet-like shapes emerge when the emulsion is subject to a Poiseuille flow [27–29], leaving
the shape of the inner core essentially unaffected. More complex effects are observed in the presence
of more intense flows, such as an iper-stretching of the core in tandem with the outer drop leading
to their breakup and formation of two daughter cores [24, 30]. Hence, it is of particular relevance
to understand how the geometry of the emulsion can influence the drug transport. In this respect,
the development of semi-empirical and mechanistic models is crucial for predicting the release
performances in multiple emulsions and for improving their design. Besides providing a systematic
approach to solve these tasks, mathematical modeling can also serve as a tool to answer practical
issues, such as the identification of the parameters to tune in order to achieve a predetermined
delivery rate or the development of physico-chemical markers capturing main transport processes
[31, 32]. While previous studies have been focused on modeling drug release in multi-layered rigid
spherical microcapsules [18, 33, 34], in this work we extend the mechanistic approach to soft multiple
emulsions focussing on the shapes shown in Fig. 1, which are geometries observed at equilibrium or
with a very weak flow (a), and under extensional/shear (b), and Poiseuille flow (c), in the laminar
regime (i.e. when the Reynolds number remains below 1).
We describe the drug kinetics from a double emulsion by means of a system of diffusion equa-
tions coupled via suitable boundary and interlayer conditions. We simulate the transport of the
drug initially confined within the inner spherical core and compute its release time, by varying the
diffusivity of the shell and the permeability of the external membrane due to a surfactant. Our
results show how the geometry of the double emulsion does have an influence on the drug deliv-
ery and, in particular, how elongated droplets exhibit a faster release. Once the parameters are
identified, the proposed methodology provides a simple tool that can be used to quantitatively char-
acterize the drug transport, improve the technological performance and optimize the release rate for
therapeutic purposes. The remaining sections of this paper are structured as follows. In Sect. 2 we
describe the equations governing the kinetics of the drug in a core-shell emulsion geometry and in
Sect. 3 we illustrate the details of the numerical model involving a finite volume discretisation over
an unstructured mesh. Sect. 4 is devoted to the presentation and discussion of numerical results of
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Figure 1: Schematic representation of the cross-section of the droplet comprised of an internal circular core Ω0, and an
enveloping denser fluid shell Ω1. A thin membrane (shown in blue) is present at the surface modelling the surfactant
finite resistance.
Figure 2: A snapshot of a typical double emulsion (from [5]).
a drug releasing round-shaped droplet, under different flow conditions.
2 Drug diffusion from a multi-layer droplet
In the most general case, a composite emulsion-based droplet is comprised of n enveloping concentric
liquid shells. This multi-layer droplet is immersed in an external release medium (or bulk fluid)
that, for the purposes of this work, is assumed stable and steady. Without loss of generality
and with reference to Fig. 2, we restrict our analysis to a single vesicle, utilizing the superposition
principle for the release from a number of identical droplets. Among several possible double emulsion
configurations [5], we consider here a droplet Ω constituted of two concentric layers of fluid, a circular
core Ω0 (layer 0) and an enveloping shell Ω1 (layer 1). As the emulsion is fabricated through a
confined fluid flow, the external layer is typically deformed in the flow direction. Neglecting droplet
microfluidics and deformation, we restrict our attention to the drug delivery and the characteristics
of the release for a fixed shape. In actual fact, with the superimposed flow at steady state, droplets
assume and maintain a variety of typical shapes, from the round and oblate spheroid, to an ellipsoid
or bullet-like geometry, with the spherical shape of the internal core preserved (see Fig. 1). In this
study we consider a 2D cross section of the droplet aligned with the superimposed two-dimensional
3
fluid flow. Generally a surfactant is added to the surface of the vesicle to prevent coalescence [16],
and this results in a additional resistance to the drug release. To include this effect, a thin membrane
is assumed at the surface of the droplet with a surface mass transfer coefficient P (m/s) expressing
the surfactant finite resistance (Fig. 1) [33, 34].
In a steady and stable double emulsion, we assume the drug kinetics are governed by a purely
diffusive two-layer model, where the evolution of the concentrations, c0(x, t) and c1(x, t), in the
core and shell respectively, are governed by a set of 2D linear diffusion equations [33, 34]:
∂c0
∂t
= ∇ · (D0∇c0), x ∈ Ω0, (2.1)
∂c1
∂t
= ∇ · (D1∇c1), x ∈ Ω1, (2.2)
paired with the following interlayer, boundary and initial conditions
c0 = c1, D0∇c0 · nΓ = D1∇c1 · nΓ, x ∈ Γ, (2.3)
D1∇c1 · nΩ = −Pc1, x ∈ ∂Ω, (2.4)
c0(x, 0) = C0, x ∈ Ω0, (2.5)
c1(x, 0) = C1, x ∈ Ω1, (2.6)
where C0, C1 > 0 are constants, Γ is the interface between Ω0 and Ω1, nΓ is a unit normal to Γ and
nΩ is the unit normal to ∂Ω directed outwards from Ω . In the above equations, the parameters
D0, D1 are the drug diffusion coefficients of the two layers and P is the specified mass transfer
coefficient at the surface [33, 34]. In the limit P → 0, we have an impermeable membrane, when
P →∞ we recover a perfect sink condition (no resistance).
All the variables, the parameters and the equations are scaled by means of the change of variables:
x→ x
χ
, t→ Dmax
χ2
t, ci → ci
Cmax
, i = 0, 1, (2.7)
and by redefining the non-dimensional constants:
Di → Di
Dmax
, Ci → Ci
Cmax
, P → P χ
Dmax
, i = 0, 1, (2.8)
where χ is a characteristic length scale of Ω1, Cmax = max(C0, C1) and Dmax = max(D0, D1).
3 Numerical method
3.1 Solving for the drug concentration
The non-dimensionalized analogue of the diffusion model (2.1)–(2.6) is solved numerically by dis-
cretizing in space using a finite volume method on an unstructured mesh (see, e.g., [35]). To perform
the meshing, we use the mesh generator GMSH [36] to construct meshes consisting of a set triangu-
lar elements (TΩ). Each element is located entirely within either Ω0 or Ω1 (i.e., elements adjacent
to the interface, Γ, have an edge that aligns with the interface) with TΩ0 and TΩ1 used to denote
the set of elements located in Ω0 and Ω1, respectively.
We employ a vertex-centered strategy, where finite volumes are constructed around each node
by connecting the centroid of each triangular element to the midpoint of its edges (Fig. 3). Spatial
discretization is applied to the following equivalent form of (2.1)–(2.2):
∂c
∂t
= ∇ · (D(x)∇c) , x ∈ Ω,
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Figure 3: Notation used in the finite volume discretization. Depicted is the finite volume (Vk) corresponding to an
arbitrary internal node k with the boundary of the finite volume shown using a dashed line. The blue dot locates the
midpoint of edge σ (xσ) and the length of the red edge, labelled σ, is Lσ.
where
c(x, t) =
{
c0(x, t), if x ∈ Ω0,
c1(x, t), if x ∈ Ω1,
D(x) =
{
D0, if x ∈ Ω0,
D1, if x ∈ Ω1.
Let N be the number of nodes in the mesh, c˜k := c˜k(t) be the numerical approximation to c(xk, t)
and Vk be the finite volume surrounding node k for all k = 1, . . . , N (Fig. 3). The finite volume
discretization yields the follow system of spatially-discrete equations:
dc˜k
dt
=
1
|Vk|
∑
σ∈Ek
Fk,σ, k = 1, . . . , N, (3.1)
where Ek is the set of edges comprising the boundary of Vk, |Vk| is the area of Vk and Fk,σ is a
numerical approximation to the (negative) flux
∫
σD(x)∇c · nk,σ dx with nk,σ denoting the unit
vector normal to edge σ directed outward from Vk (Fig. 3). The value of Fk,σ depends on whether
the edge σ is located in the interior of the droplet (Ω) or along the boundary (∂Ω):
Fk,σ =
[D(xσ)(∇˜c)σ · nk,σ]Lσ, if xσ ∈ Ω,−P c˜σLσ, if xσ ∈ ∂Ω, (3.2)
with xσ and Lσ denoting the midpoint and length of edge σ, respectively. The quantities c˜σ and
(∇˜c)σ are numerical approximations to c(xσ, t) and ∇c(xσ, t) computed/discretised by assuming
the concentration varies linearly within each triangular element. The discretised forms for c˜σ and
(∇˜c)σ are expressed in terms of c˜k for k ∈ Nσ, where Nσ is the set of three nodes corresponding to
the three vertices of the triangular element in which σ is located. In summary, the finite volume
equations (3.1)–(3.2) define a system of linear ordinary differential equations, expressible in matrix
form as:
dc
dt
= Ac, c(0) = c0, (3.3)
where c = (c˜1, . . . , c˜N )
T , A is an N×N matrix and c0 is the discretised form of the initial conditions
(2.5)–(2.6) with the kth entry of c0 equal to C0 if xk ∈ Ω0, C1 if xk ∈ Ω1 and the weighted average
(|Vk ∩ Ω0|C0 + |Vk ∩ Ω1|C1)/|Vk| if xk ∈ Γ. The system (3.3) is solved using MATLAB’s built-in
ode15s solver with the default options and tolerances [37].
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3.2 Computing the drug mass
The drug mass in the droplet layers (core and shell) and the total drug mass are defined as follows:
M0(t) =
∫
Ω0
c0(x, t) dx, M1(t) =
∫
Ω1
c1(x, t) dx, MT (t) = M0(t) +M1(t). (3.4)
These quantities are calculated from the numerical solution described in Sect. 3.1 by integrating
the piecewise linear concentration across each element yielding the approximations:
M0(t) ≈
∑
E∈TΩ0
mean{c˜k(t) | k ∈ NE} · |E|, M1(t) ≈
∑
E∈TΩ1
mean{c˜k(t) | k ∈ NE} · |E|, (3.5)
MT (t) ≈
∑
E∈TΩ
mean{c˜k(t) | k ∈ NE} · |E|, (3.6)
where NE is the set of three nodes corresponding to the three vertices of triangular element E and
|E| is the area of element E. With the masses in both layers calculated, the fractional released
mass, i.e. the fraction of the initial mass that has been released at time t, is computed as
Mr(t) = 1− MT (t)
MT (0)
. (3.7)
Note that Mr(0) = 0 and lim
t→∞Mr(t) = 1 since limt→∞M0(t) = M1(t) = 0. The release time, defined
as the time t∗ at which Mr(t∗) ≈ 1, is specified in the next section.
4 Results and discussion
Among a variety of configurations, we want to analyze the sensitivity of the release with respect to
the properties of the shell Ω1 for varying mass transfer coefficient P and diffusion coefficient D1,
when the core Ω0 and the initial drug mass are kept unchanged. The parameters used are consistent
with typical values in the literature and listed in Table 1.
Table 1: Nondimensional range and value of the parameters
Model parameters Physical range Simulated values References
R0 (µm) 0.5− 50 40 [2, 4, 16, 38, 39]
R1 (µm) 50− 100 50, 80 [2, 4, 16, 39, 40]
D0 (m
2/s) 10−9-10−10 10−10 [41]
D1 (m
2/s) 10−11-10−13 10−12, 10−13 [41]
P (m/s) 0-1 10−7, 2 · 10−4 [40, 42, 43]
To fix ideas, without loss of generality, we consider Ω0 as a circle centered at the origin with
radius R0 = 40µm (see Fig. 4). On the other hand, the shape of Ω1 becomes a key factor of the
release and we analyze the dependence of the drug delivery on the geometry of the shell. Three
different shapes are considered for Ω1, each centered at the origin and of the same area (see Fig. 4):
• circle with radius R1;
• ellipse with horizontal semi-axis length γR1 and vertical semi-axis length R1/γ where γ > 1;
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Ellipse
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Figure 4: Schematic representation of the cross-section of the droplet comprised of an internal circular core Ω0, and
an enveloping shell Ω1. Three different 2D shapes are considered for Ω1: circle, ellipse and bullet, all with the same
area. This two-layer emulsion-based vesicle is surrounded by a surfactant layer (blue boundary) having a mass transfer
coefficient P (m/s).
Figure 5: Triangular meshes for the three droplet shapes of equal area: circle (left column) consisting of 1769 nodes
and 3408 triangular elements, an ellipse with e = 0.95 (middle column) consisting of 1797 nodes and 3432 triangular
elements and a bullet (right column) consisting of 1785 nodes and 3438 triangular elements.
• bullet-like shape with boundary described by the following quartic (so-called bean) curve:
(Rˆ1 − x)4 + (Rˆ1 − x)2y2 + y4 − 2Rˆ1(Rˆ1 − x)[(Rˆ1 − x)2 + y2] = 0,
where choosing Rˆ1 =
√
3
√
3
7 R1 ≈ 0.8616R1 ensures the area enclosed by the quartic curve is
the same as the areas of the circle and ellipse above.
For all three configurations, the size of Ω1 is characterized by R1 so we choose χ = R1 in the non-
dimensionalization (2.7)–(2.8). For the ellipse configuration, the eccentricity, e, is defined, which is
related to γ by the formula e =
√
1− 1/γ4. At initial time, we assume all the drug is in the internal
core (C0 = 1) while the external shell is assumed empty (C1 = 0).
First, we present results for the case of R1 = 80µm and γ = 1.8. The finite volume discretisation
outlined in Sect. 3.1 is performed using the unstructured meshes shown in Fig. 5. Each of these
meshes have an equivalent level of refinement with the prescribed mesh element size at all points
used to describe the geometries in GMSH set to be equal1. Further refining of the mesh did not
1See GMSH documentation available at http://gmsh.info/ for more details.
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visually alter the concentration fields (grid independence). Fig. 6 shows the concentration field in
the case of the different droplet configurations (left-right) at three times (top-down). It turns out
that for the above parameters, the sensitive values are in the range: 10−8 ≤ P ≤ 10−3. In the
limit, for P < 10−9, the surface acts as an impermeable barrier (as P → 0) (release prevented), for
P > 10−1, the droplet surface results in perfect contact with the surrounding external medium (as
P →∞) (fastest release).
The effect of the combined multi-layer diffusivity is similar to that of other releasing systems
[44]. Drug mass is transported from the core to the surrounding shell, and thereafter released to the
external medium. Mass is monotonically decreasing in the core, but is first increasing up to some
upper bound and then decaying asymptotically in the shell layer (Fig. 7). In the external release
medium the mass progressively accumulates at a time depending on the diffusive properties of the
two-layer droplet and the resistance P . In other words, due to the absorbing condition (2.4), all
drug mass is transferred to the surrounding environment at a sufficiently long time and the total
mass is preserved and equals the initial value.
A crucial indicator is the release time (RT), measured here as:
RT = min{t |Mr(t) ≥ 0.999}. (4.1)
Additional simulations demonstrate that the time and the size of the mass peak in layer 1 is
much more correlated with the diffusivity and the size of the shell, and much less controlled by
the mass resistance of the surfactant P (see Table 2). A more sustained release occurs in the case
of a surfactant having a smaller mass transfer coefficient (P = 10−7). In Table 3 and Fig. 8, we
analyze the dependence of the release time from the geometry (ellipses with different eccentricity
and bullet-like shape) of the droplet, when the area of the vehicles remains the same. It turns
out that the bullet shape droplet has a RT comparable with that of the ellipse with e = 0.72,
and shorter of that of the circle. Fig. 9 shows the increased flux J = −D1∇c1 · nΩ (coloured
contour) at the surface due to the higher gradient of concentration, in correspondence to points of
lower curvature. Moreover, the global flux
∫
∂Ω Jds exhibits a faster release rate for the ellipsoidal
droplets. In summary, all these results demonstrate that an oblate shape promotes a faster drug
delivery, while a round geometry guarantees a more sustained release.
5 Conclusions
Multiple emulsions are highly structured fluids consisting of drops that encapsulate smaller droplets
inside. The availability of such multi-compartment vesicles with controlled size and structure have
attracted much attention as robust and versatile drug delivery systems, in equilibrium with the ex-
ternal flow. In this work we analyze the structure of a double emulsion in which each drop contains
a single internal droplet, thus developing a core-shell structure whose core diameter and shell thick-
ness and shape can be controlled. A two-layer diffusion model for the drug release is developed and
solved numerically. Results show the importance of the parameters on the drug kinetics, demon-
strating how the oblate shape exhibits a faster drug delivery, while a round geometry promotes a
more sustained release. Additional efforts are needed to improve microfluidic platforms to generate
and analyze fluid droplets with higher stability and biocompatibility and to achieve the successful
translation of emulsion-based drug delivery systems into clinical applications. Therefore, in a future
work, we plan to couple the present model with the microfluidics allowing the investigation of the
effects of interaction of underlying flow and drug release under conditions mimicking the in-vitro
and in-vivo systems. The predictive capability of the model will provide important guidance in
fabricating double emulsions that can guarantee a controlled drug delivery to the target sites at
desired rates and time.
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Figure 6: Concentration field at t = 1 min (top row), t = 6 mins (middle row) and t = 1 hr (bottom row) for the
three droplet shapes of equal area: circle (left column), an ellipse with e = 0.95 [γ = 1.8] (middle column) and a
bullet (right column) (cfr. Fig. 7). Results are produced using the meshes shown in Fig. 5 and the parameter values:
R0 = 40µm, R1 = 80µm, D1 = 10
−13 m2/s, P = 2 · 10−4 m/s.
Figure 7: Mass profiles for the three droplet shapes of equal area (cfr. Fig. 6). Relative mass = M0(t)/MT (0) (Core),
M1(t)/MT (0) (Shell), MT (t)/MT (0) (Total) and Mr(t)/MT (0) (Released) [cf. Eqs (3.4)–(3.7)]. Results are produced
using the meshes shown in Fig. 5 and the parameter values used in Fig. 6. Legend applies across all three figures.
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Table 2: Release time for a circular droplet for varying values of R1 (µm), D1 (m
2/s) and P (m/s). All other
parameters are held fixed: R0 = 40µm and D0 = 10
−10 m2/s.
R1 D1 P RT (hr) RT (HH:MM:SS)
50 10−12 2 · 10−4 0.41 00:24:38
50 10−12 1 · 10−7 0.87 00:51:57
80 10−12 2 · 10−4 1.95 01:56:57
80 10−12 1 · 10−7 2.59 02:35:36
50 10−13 2 · 10−4 4.08 04:04:34
50 10−13 1 · 10−7 4.51 04:30:42
80 10−13 2 · 10−4 19.47 19:28:20
80 10−13 1 · 10−7 20.08 20:04:42
Table 3: Release time (4.1) from ellipsoidal droplets with the same area as a function of eccentricity. The values
of eccentricity (e) are rounded to two decimal places and correspond to γ = 1, 1.2, . . . , 1.9. We also compare with
the circular shape (e = 0) and the bullet shape. All other parameters are held fixed: R0 = 40µm, R1 = 80µm,
D0 = 10
−10 m2/s, D1 = 10−13 m2/s and P = 2 · 10−4 m/s.
Shape e RT (hr) RT (HH:MM:SS)
Circle 0 19.47 19:28:21
Ellipse 0.56 19.01 19:00:53
0.72 17.79 17:47:14
0.81 16.16 16:09:23
0.86 14.33 14:19:46
0.90 12.46 12:27:23
0.92 10.62 10:37:00
0.94 8.86 08:51:18
0.95 7.18 07:10:36
0.96 5.55 05:32:52
Bullet N/A 17.86 17:51:28
Figure 8: Reduction of the release time (RT, Eq. (4.1)) for the ellipsoidal shaped droplet with increasing eccentricity
(e) (cfr. Table 3). All other parameters are held fixed: R0 = 40µm, R1 = 80µm, D0 = 10
−10 m2/s, D1 = 10−13 m2/s
and P = 2 · 10−4 m/s.
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Figure 9: Boundary flux J = −D1∇c1 · nΩ at x ∈ ∂Ω and total boundary flux
∫
∂Ω
J ds at t = 1 hr for the three
droplet shapes of equal area: circle (left column), an ellipse with e = 0.95 [γ = 1.8] (middle column) and a bullet
(right column) (cfr. Fig. 6, bottom row). Results are produced using the meshes shown in Fig. 5 and the parameter
values used in Fig. 6.
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